CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells

STAR Protoc. 2022 Mar 18;3(2):101257. doi: 10.1016/j.xpro.2022.101257. eCollection 2022 Jun 17.

Abstract

The in vitro recapitulation of chromosomal rearrangements is a necessary tool for understanding malignancy at the molecular level. Here, we describe the targeted induction of a large chromosomal inversion (>3.7 Mbp) through CRISPR-Cas9-mediated genome editing. As inversions occur at low frequency following Cas9 cleavage, we provide a detailed screening approach of FACS-sorted, single-cell-derived clonal human bronchial epithelial cell (HBEC) cultures. The protocol provided is tailored to HBECs; however, it can be readily applied to additional adherent cellular models. For complete details on the use and execution of this protocol, please refer to Zampetidis et al. (2021).

Keywords: CRISPR; Cancer; Cell Biology; Cell culture; Flow Cytometry/Mass Cytometry; Molecular Biology; Sequencing; Single Cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems* / genetics
  • Cells, Cultured
  • Chromosome Inversion*
  • Epithelial Cells
  • Gene Editing / methods
  • Humans